By Dorothy Atkins (May 13, 2022, 9:25 PM EDT) -- A Black Diamond Venture executive testified in ex-Theranos executive Ramesh "Sunny" Balwani's criminal fraud trial Wednesday that he moved quickly under a Theranos-imposed deadline to invest an additional $5.4 million in the blood-testing company in 2013, working Christmas Eve and Day, in part because of the Theranos-Walgreens partnership that Balwani spearheaded.
Chris Lucas recalled that former Theranos CEO Elizabeth Holmes notified him in early December 2013 that the private blood-testing company was offering Theranos stock by invitation only for $15 per share, but that buyers had to make their purchases by the end of the year.
Lucas wanted more time to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!